Treatment for Elevated Pulmonary Pressure

Initial Assessment and Classification

• The European Respiratory Journal recommends that all patients with suspected pulmonary hypertension should undergo systematic evaluation using WHO functional class, exercise capacity, echocardiographic findings, laboratory values, and hemodynamic parameters to guide therapeutic decisions 6
• Pulmonary hypertension is classified into five groups based on etiology, with treatment approaches differing significantly between groups 6

Treatment Based on Pulmonary Hypertension Classification

• The American College of Chest Physicians recommends that for non-vasoreactive PAH patients or those who fail CCB therapy, monotherapy with either endothelin receptor antagonists, PDE-5 inhibitors, or soluble guanylate cyclase stimulator is recommended for WHO Functional Class I-II patients 3
• The American College of Chest Physicians recommends that for WHO Functional Class III PAH patients, combination therapy with ambrisentan and tadalafil is recommended 3
• The American College of Chest Physicians recommends that for WHO Functional Class IV PAH patients, continuous IV epoprostenol, IV treprostinil, or SC treprostinil is strongly recommended 3

Supportive and Adjunctive Measures

• The Lancet Respiratory Medicine recommends that diuretics should be used for management of fluid retention and right heart failure 7
• The Lancet Respiratory Medicine recommends that supplemental oxygen should be used to maintain oxygen saturations >91%, especially for patients with hypoxemia 7

Treatment Goals and Follow-up

• The European Respiratory Journal recommends that regular follow-up every 3-6 months for stable patients, more frequently for advanced disease 6
• The European Respiratory Journal recommends that assessment should include functional class, exercise capacity tests, and echocardiographic evaluation 6

Advanced Options

• The American College of Chest Physicians recommends that for patients with inadequate response to maximal medical therapy, lung transplantation should be considered 3
• The American College of Chest Physicians recommends that palliative care services should be incorporated for symptom management in advanced disease 3

Common Pitfalls and Caveats

• The American College of Chest Physicians recommends that delayed referral to specialized PH centers can result in inappropriate treatment and worse outcomes 1, 2
• The Lancet Respiratory Medicine recommends that inappropriate use of pulmonary vasodilator medications in patients with PH due to left heart disease can worsen outcomes 7